Axxzia (4936) · RiskMitigated
Response to Changes in Domestic and Overseas Regulations and Renewal of Licenses and Approvals
First written in FY2021. 1 of 2 entries say "Mitigated", first in FY2024. Latest entry: FY2024.
2entries
4years
0from disclosures
How it moved
Same theme, other companies
Risk of Maintaining Licenses to Manufacture and Market Cosmetics and Quasi-DrugsA theme 6 companies write about · 6 as a headwind · 0 as a tailwind
0 other companies' latest entry also says "Mitigated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2024MitigatedAnnual report
「29 May 2023 Cosmetics manufacturing and marketing license Tokyo 28 May 2028」
The company disclosed that the cosmetics manufacturing and marketing license was obtained on 29 May 2023 and is valid through 28 May 2028. This indicates the renewed license status following the previously reported expiration in 2023. - FY2021First statedAnnual report
「The group handles a diverse range of products, mainly cosmetics and health foods, in Japan and overseas and is subject to a wide range of laws and regulations. In the future, changes to the Pharmaceutical and Medical Devices Act and the renewal of licenses and permits upon expiration may result in additional costs for further measures.」
The company identifies changes to or introduction of the Pharmaceutical and Medical Devices Act, the Food Sanitation Act, the Act against Unjustifiable Premiums and Misleading Representations, the Electronic Commerce Act, and other regulations, as well as the renewal of licenses and permits related to cosmetics manufacturing, as risks. The expiration date of the principal licenses and permits is 28 May 2023.